Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-18 4:15 pm Sale |
2023-04-12 | 13G | Amryt Pharma plc AMYT |
Athyrium Opportunities III Acquisition 2 LP | 0 0.000% |
-44,286,346 (Position Closed) |
Filing History |
| 2023-02-14 4:19 pm Sale |
2022-12-31 | 13G | CareMax, Inc. CMAX |
Athyrium Opportunities III Acquisition 2 LP | 139,369 3.800% |
-10,205 (-6.82%) |
Filing History |
| 2022-02-11 4:34 pm Purchase |
2021-12-31 | 13G | CareMax, Inc. CMAX |
Athyrium Opportunities III Acquisition 2 LP | 149,574 5.200% |
149,574 (New Position) |
Filing History |
| 2021-02-12 08:01 am Purchase |
2020-07-08 | 13G | Amryt Pharma plc AMYT |
Athyrium Opportunities III Acquisition 2 LP | 44,286,346 24.800% |
44,286,346 (New Position) |
Filing History |